# Editas Medicine, Inc.: Form 8-K, filed Apr 14, 2022

- Company: [Editas Medicine, Inc.](/companies/edit.md) (CIK 1650664)
- Form: 8-K
- Filed: 2022-04-14
- Accepted by EDGAR: Apr 14, 2022, 07:40 ET
- Period: 2022-04-12
- Accession: 0001558370-22-005418
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1650664/000155837022005418/edit-20220412x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1650664/000155837022005418/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1650664/000155837022005418/edit-20220412x8k.htm

Filed Apr 14, 2022.
Source: SEC EDGAR, the filing index for accession 0001558370-22-005418. Last ingested by Listed: Nov 6, 2026, 17:42 ET. No prices; not investment advice.